we conclude that ifosfamide is an important alkylating agent without apparent complete cross-resistance with cyclophosphamide , and as such should be further investigated for determination of its activity in patients with pediatric neoplasms and considered for incorporation into phase ii-iii trials for certain tumors .
C0020823
ifosfamide
C0010583
cyclophosphamide